William M Bennett. Show Affiliations »
Abstract
Mesh： See more » Antibodies, Monoclonal/therapeutic useDrug LabelingDrug Utilization/ethicsDrug Utilization/standardsHumansInflammatory Bowel Diseases/drug therapyInfliximabUnited StatesUnited States Food and Drug AdministrationVasculitis, Leukocytoclastic, Cutaneous/drug therapy
Substances： See more » Antibodies, MonoclonalInfliximab
Year: 2004 PMID： 14978188 DOI： 10.1097/01.asn.0000118323.41076.01
Source DB: PubMed Journal: J Am Soc Nephrol ISSN： 1046-6673 Impact factor: 10.121